BRIEF-Ipsen says its partner, Lexicon Pharmaceuticals, announces positive results from Telestar Phase 3 study
August 03, 2015 at 01:18 AM EDT
* Ipsen's partner, Lexicon Pharmaceuticals, announces positive results from Telestar Phase 3 study showing that telotristat etiprate is effective in the treatment of carcinoid syndrome caused by neuroendocrine tumors not ade
